Only about three million of the 20 million courses of Pfizer’s antiviral Paxlovid that the administration has ordered since last November have been prescribed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.